58. Susceptibility to lung cancer is associated with genetic polymorphisms of CYP1A1、GSTM1

Objective: To investigate the association of lung cancer susceptibility with genetic Polymorphism of CYP1A1 and GSTM1. Methods: The study was conducted on 65 lung cancer cases and 60 no-cancer controls. The genetic polymorphism both CYP1A1 and GSTM1 were performed in cancer tissues of all patients and peripheral blood leukocytes of no-cancer controls. First by RFLP-PCR, then after incubating with restriction enzyme Ncol and Hinfl. Results: ①There were no significant differences in the frequency distribution of CYP1A1 polymorphisms between lung cancer patients and controls, but the frequency of CYP1A1(Val/Val) was significant higher than that controls (P<0.05). ②If OR for CYP1A1 (Ile/Ile) genotype was 1.0, the OR of CYP1A1 (Ile/VaL)、CYP1A1 (Val/Val) was 1.68 (95%CI, 0.79～3.59) and 3.2 (95%CI, 1.06～10.26), respectively. ③The significant difference were observed that GSTM1(-) became markedly expressed (63.1%, 41/65) in elung cancer patients than in the corresponding controls (45%, 27/60) (P<0.05), OR was 2.09 (95%CI, 1.02～4.26); ④When analysis combined CYP1A1 and GSTM1 genotype, we found that individual who take along CYP1A1 (Ile/Ile)/GSTM1 (-) or CYP1A1 (Ile/Val+Val/Val)/GSTM1 (+) genotype had higher odds ratio than CYP1A1 (Ile/Ile)/GSTM1 (+) genotype, the OR was 3.82 (95%CI, 1.27～11.45) and 3.5 (95%CI 1.18～10.41), respectively, but the CYP1A1 (Val/Val) / GSTM1 (-) genotype was the hightest odds ratio, the OR was 10.5 (95%CI, 1.70～64.73). ⑤We observed that the individual who carry CYP1A1(Val/Val) genotype can increased risk of squamous cell carcinoma of lung (P<0.05), OR was 2.75 (95%CI, 1.24～6.17), there was no significant associated of pathologic with GSTM1 genotype. ⑥Stratified analysis suggested an interaction between cigarettes smoking and CYP1A1 (Ile/Val+Val/Val)、GSTM1 (-) genotype. Conclusion: ①The individuals who carried genotype of CYP1A1 (Val/Val) and GSTM1 (-) were susceptible to lung cancer. ②the individuals who carried CYP1A1 (Ile/Ile) /GSTM1 (-) or CYP1A1 (Ile/Val+Val/Val) /GSTM1 (+) genotype with higher risk of developing lung cancer than that CYP1A1 (Ile/Ile)/GSTM1 (+) genotype. ③There were interaction between smoking and CYP1A1 (Ile/Val+Val/Val)、GSTM1 (-)